{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"ghk-cu-metformin","title":"GHK-Cu × Metformin","body":"## GHK-Cu and metformin — where repair fits\nmetformin represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether ghk-cu mechanisms address underlying repair deficits.\n\n## What is known about GHK-Cu with metformin\nStudied regenerative or supportive role in collagen / skin matrix — see peptide root ledger.\n\nTarget condition: metformin.\nBody system: Metabolic tool; B12/mitochondrial concerns at chronic use — context dependent..\n\n## Logic chain — GHK-Cu to metformin\n1. ghk-cu studied regenerative or supportive role in collagen / skin matrix — see peptide root ledger..\n2. metformin involves metabolic tool; b12/mitochondrial concerns at chronic use — context dependent. dysfunction.\n3. If ghk-cu reaches the affected tissue, it may shift the repair/breakdown balance.\n4. This chain is under investigation.\n\n## GHK-Cu parent claims that bear on metformin\n- Plasma GHK levels measure approximately 200 ng/mL at age 20 and decline to approximately 80 ng/mL by age 60.\n- In human dermal fibroblast cultures, GHK-Cu at nanomolar concentrations increases synthesis of collagen types I, III, and IV as well as elastin and glycosaminoglycans.\n- Placebo-controlled topical application studies in women around age 50 reported improved skin quality parameters and increased collagen deposition in skin biopsies.\n- A registered Phase 2 randomized double-blind trial (NCT07437586) is evaluating topical GHK-Cu gel versus vehicle for acute skin wound re-epithelialization in healthy adults.\n- 2018 review on GHK-Cu regenerative actions based on gene data, covering wound healing, skin regeneration, anti-inflammatory effects.\n\n## Evidence tier for GHK-Cu with metformin\nEvidence status unclear — research ongoing.\n\n## What we do not know about GHK-Cu with metformin\n- Whether ghk-cu reaches metformin tissue at functional concentrations\n- Optimal dosing, route, and duration for this target\n- Interaction with standard-of-care treatments for metformin\n- Long-term safety profile in this population\n\n## Safety note\n\nAll peptide use for metformin is research-context only. Not medical advice. Consult a physician before any experimental compound.","hero":null,"images":[],"style":{},"tags":["peptide"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/ghk-cu-metformin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[],"sources":[],"reviews":[],"extra":{},"has_traversal":false,"register":"standard","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T18:05:18.696Z","model":"grok-4.3","role":"writer","action":"draft","payload":{"title":"GHK-Cu × Metformin","register":"standard","body":"## Overview\nEvidence is being populated by Grok web search.","claims":[],"sources":[]},"rationale":"","tokens_in":0,"tokens_out":0,"cost":0,"prev_hash":"genesis","hash":"9b1ff80e0162184458d539c8ad2abdfcd8e00fbfcab6b259bcad06264c0510eb"}],"provenance":[{"ts":"2026-06-29T18:05:18.696Z","model":"grok-4.3","action":"populate-init","prompt":"","input":"","response":"","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"d119599aae8e351826d52578cb5c19f890132444ef2f1d200ab8dd1ccac94685"},{"ts":"2026-07-17T02:39:23.068Z","model":"owner","action":"voxel_divide","prompt":"","input":"ghk-cu-metformin","response":"15 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d119599aae8e351826d52578cb5c19f890132444ef2f1d200ab8dd1ccac94685","hash":"67a4d3e5e771f90121e0d01ab88e4109c77893d127aea024678b8792bda2913a"}],"energy":{"passes":2,"tokens_in":0,"tokens_out":0,"tokens_total":0,"cost_usd":0,"models":{"grok-4.3":1,"owner":1},"head":"67a4d3e5e771f90121e0d01ab88e4109c77893d127aea024678b8792bda2913a"},"posted_at":"2026-06-29T18:05:18.696Z","created_at":"2026-06-29T18:05:18.696Z","updated_at":"2026-08-08T04:22:52.421Z","machine":{"shape":"article.machine/v1","slug":"ghk-cu-metformin","kind":"article","read":{"human":"https://miscsubjects.com/a/ghk-cu-metformin","json":"https://miscsubjects.com/api/articles/ghk-cu-metformin","bundle":"https://miscsubjects.com/api/articles/ghk-cu-metformin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":0,"sources":0,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/ghk-cu-metformin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=ghk-cu-metformin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ghk-cu-metformin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ghk-cu-metformin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/ghk-cu-metformin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"ghk-cu-metformin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/ghk-cu-metformin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/ghk-cu-metformin","json":"/api/articles/ghk-cu-metformin","markdown":"/api/articles/ghk-cu-metformin/bundle?format=markdown","skill":"/api/articles/ghk-cu-metformin/skill","topology":"/api/articles/ghk-cu-metformin/topology","versions":"/api/articles/ghk-cu-metformin/revisions","invocations":"/api/articles/ghk-cu-metformin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"ghk-cu-metformin","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"724d5c9535c71bbbac16dbad57ee70c658e4a68d8dbdad65c5d845c90f501ae6","object":{"object_type":"article-object","identity":{"id":"article:ghk-cu-metformin","slug":"ghk-cu-metformin","title":"GHK-Cu × Metformin"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/ghk-cu-metformin","role":"explain","audience":"human"},"skill":{"route":"/api/articles/ghk-cu-metformin/skill","role":"direct behavior","audience":"model","content":"---\nname: ghk-cu-metformin\ndescription: Apply the GHK-Cu × Metformin article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# GHK-Cu × Metformin\n\nThis Skill is the behavioral expression of [the canonical article](/a/ghk-cu-metformin). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/ghk-cu-metformin.\n- Read claims and relationships at /api/articles/ghk-cu-metformin/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nGHK-Cu and metformin — where repair fits metformin represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether ghk-cu mechanisms address underlying repair deficits. What is known \n\n## Representations\n\n- Human: /a/ghk-cu-metformin\n- JSON: /api/articles/ghk-cu-metformin\n- Relationships: /api/articles/ghk-cu-metformin/topology\n- History: /api/articles/ghk-cu-metformin/revisions\n"},"json":{"route":"/api/articles/ghk-cu-metformin","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/ghk-cu-metformin/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","ghk","cu","metformin"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/ghk-cu-metformin/invocations?status=success","failure_events":"/api/articles/ghk-cu-metformin/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"ghk-cu-metformin","title":"GHK-Cu × Metformin","body":"## GHK-Cu and metformin — where repair fits\nmetformin represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether ghk-cu mechanisms address underlying repair deficits.\n\n## What is known about GHK-Cu with metformin\nStudied regenerative or supportive role in collagen / skin matrix — see peptide root ledger.\n\nTarget condition: metformin.\nBody system: Metabolic tool; B12/mitochondrial concerns at chronic use — context dependent..\n\n## Logic chain — GHK-Cu to metformin\n1. ghk-cu studied regenerative or supportive role in collagen / skin matrix — see peptide root ledger..\n2. metformin involves metabolic tool; b12/mitochondrial concerns at chronic use — context dependent. dysfunction.\n3. If ghk-cu reaches the affected tissue, it may shift the repair/breakdown balance.\n4. This chain is under investigation.\n\n## GHK-Cu parent claims that bear on metformin\n- Plasma GHK levels measure approximately 200 ng/mL at age 20 and decline to approximately 80 ng/mL by age 60.\n- In human dermal fibroblast cultures, GHK-Cu at nanomolar concentrations increases synthesis of collagen types I, III, and IV as well as elastin and glycosaminoglycans.\n- Placebo-controlled topical application studies in women around age 50 reported improved skin quality parameters and increased collagen deposition in skin biopsies.\n- A registered Phase 2 randomized double-blind trial (NCT07437586) is evaluating topical GHK-Cu gel versus vehicle for acute skin wound re-epithelialization in healthy adults.\n- 2018 review on GHK-Cu regenerative actions based on gene data, covering wound healing, skin regeneration, anti-inflammatory effects.\n\n## Evidence tier for GHK-Cu with metformin\nEvidence status unclear — research ongoing.\n\n## What we do not know about GHK-Cu with metformin\n- Whether ghk-cu reaches metformin tissue at functional concentrations\n- Optimal dosing, route, and duration for this target\n- Interaction with standard-of-care treatments for metformin\n- Long-term safety profile in this population\n\n## Safety note\n\nAll peptide use for metformin is research-context only. Not medical advice. Consult a physician before any experimental compound.","hero":null,"images":[],"style":{},"tags":["peptide"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/ghk-cu-metformin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[],"sources":[],"reviews":[],"extra":{},"has_traversal":false,"register":"standard","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T18:05:18.696Z","model":"grok-4.3","role":"writer","action":"draft","payload":{"title":"GHK-Cu × Metformin","register":"standard","body":"## Overview\nEvidence is being populated by Grok web search.","claims":[],"sources":[]},"rationale":"","tokens_in":0,"tokens_out":0,"cost":0,"prev_hash":"genesis","hash":"9b1ff80e0162184458d539c8ad2abdfcd8e00fbfcab6b259bcad06264c0510eb"}],"provenance":[{"ts":"2026-06-29T18:05:18.696Z","model":"grok-4.3","action":"populate-init","prompt":"","input":"","response":"","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"d119599aae8e351826d52578cb5c19f890132444ef2f1d200ab8dd1ccac94685"},{"ts":"2026-07-17T02:39:23.068Z","model":"owner","action":"voxel_divide","prompt":"","input":"ghk-cu-metformin","response":"15 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d119599aae8e351826d52578cb5c19f890132444ef2f1d200ab8dd1ccac94685","hash":"67a4d3e5e771f90121e0d01ab88e4109c77893d127aea024678b8792bda2913a"}],"energy":{"passes":2,"tokens_in":0,"tokens_out":0,"tokens_total":0,"cost_usd":0,"models":{"grok-4.3":1,"owner":1},"head":"67a4d3e5e771f90121e0d01ab88e4109c77893d127aea024678b8792bda2913a"},"posted_at":"2026-06-29T18:05:18.696Z","created_at":"2026-06-29T18:05:18.696Z","updated_at":"2026-08-08T04:22:52.421Z","machine":{"shape":"article.machine/v1","slug":"ghk-cu-metformin","kind":"article","read":{"human":"https://miscsubjects.com/a/ghk-cu-metformin","json":"https://miscsubjects.com/api/articles/ghk-cu-metformin","bundle":"https://miscsubjects.com/api/articles/ghk-cu-metformin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":0,"sources":0,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/ghk-cu-metformin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=ghk-cu-metformin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ghk-cu-metformin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ghk-cu-metformin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/ghk-cu-metformin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"ghk-cu-metformin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/ghk-cu-metformin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/ghk-cu-metformin","json":"/api/articles/ghk-cu-metformin","markdown":"/api/articles/ghk-cu-metformin/bundle?format=markdown","skill":"/api/articles/ghk-cu-metformin/skill","topology":"/api/articles/ghk-cu-metformin/topology","versions":"/api/articles/ghk-cu-metformin/revisions","invocations":"/api/articles/ghk-cu-metformin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"ghk-cu-metformin","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"724d5c9535c71bbbac16dbad57ee70c658e4a68d8dbdad65c5d845c90f501ae6"}}}